No doubt 2025 will usher in many more advances in CRISPR therapies, thanks to the FDA’s new Platform Technology Designation ...

Scientists are exploring gene editing as a way to correct trisomy at the cellular level. Using CRISPR-Cas9, researchers ...

2025年2月18日，诺贝尔化学奖得主、CRISPR 基因编辑技术先驱 Jennifer Doudna 教授团队在 Nature Biotechnology 期刊发表了题为： Single-molecule live-cell RNA imaging ...

Explore the future of organ transplants and how biotech innovations like 3D bioprinting and stem cells can solve the organ ...

Cancer cells thrive in an environment deprived of oxygen and nutrients, adapting to survive and grow. Unlike normal cells, ...

Doctors harvest stem cells from the patient’s bone marrow and then send them off to a lab, where CRISPR is used to turn up the production of another, functional version of haemoglobin. This version is ...

来自Hubrecht研究所Organoid小组的研究人员发现，特定的肠道细胞，BEST4/CA7+细胞，在对引起腹泻的细菌毒素作出反应时调节电解质和水的平衡。他们的研究结果发表在《Cell Stem Cell》杂志上，表明当暴露于细胞因子干扰素-γ (IFNγ)时，这些细胞的数量大大增加，为治疗策略提供了一个有希望的靶点。

Stem cell research and regenerative medicine are growing markets in the life science sector, and the top stem cell companies ...

Gene editing techniques may eventually allow trisomy to be treated at the cellular level, according to an in vitro ...

■ ...

Patent strengthens CVC's leading position in European CRISPR IP landscape, providing security to over 150 ERS Genomics licensees. DUBLIN and CHESTER, England, Feb. 26, 2025 /PRNew ...